We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dexamethasone and Block Duration in Upper Extremity

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2014 by University of Chicago.
Recruitment status was:  Recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01756573
First Posted: December 27, 2012
Last Update Posted: October 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Chicago
December 20, 2012
December 27, 2012
October 12, 2017
January 2013
December 2014   (Final data collection date for primary outcome measure)
analgesia duration [ Time Frame: 72 hrs ]
Same as current
Complete list of historical versions of study NCT01756573 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Dexamethasone and Block Duration in Upper Extremity
A Study of the Effect of Dexamethasone on Duration of Upper Extremity Blocks With Bupivacaine
Effect of dexamethasone on prolonging upper extremity block is well known. But it not known if the effect comes from its local effect on the nerves or from its general analgesic effect. In this study we will compare the systemic effect to its local effect to find out if there is a difference or not.
Not Provided
Interventional
Phase 4
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Duration of Pain Relief
  • Drug: Dexamthsone
  • Drug: Bupivacaine
  • Active Comparator: Bupivacaine
    Control
    Intervention: Drug: Bupivacaine
  • Experimental: Bupivacaine with Dexamethasone
    Dexamethasone will be mixed with bupivacaine
    Interventions:
    • Drug: Dexamthsone
    • Drug: Bupivacaine
  • Active Comparator: Intravenous Dexamethasone
    Dexamethasone will be given intravenously
    Interventions:
    • Drug: Dexamthsone
    • Drug: Bupivacaine
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
60
December 2014
December 2014   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • age 18-75, no contraindication to regional anesthesia,

Exclusion Criteria:

  • opioid user, chronic pain conditions, peripheral neuropathy
Sexes Eligible for Study: All
18 Years to 75 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01756573
IRB12-2192
No
Not Provided
Not Provided
University of Chicago
University of Chicago
Not Provided
Not Provided
University of Chicago
March 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP